Dale E. Bredesen
Dr. Dale E. Bredesen received an undergraduate degree from Caltech, medical degree from Duke, and served his residency and chief residency in Neurology at the University of California San Francisco (UCSF). Prior to joining the UCLA faculty and then being recruited by the Burnham Institute to direct the Program on Aging, he earned a postdoctoral fellowship in the laboratory of Nobel laureate Professor Stanley Prusiner.
He served as the founding President of the Buck Institute for Research on Aging and as Adjunct Professor at UCSF before returning to UCLA to direct the Easton Center for Alzheimer’s Disease Research, and as Professor of Molecular and Medical Pharmacology at the David Geffen School of Medicine.
Dale and his laboratory group have published over 220 research papers, established the Alzheimer’s Drug Development Network (ADDN), and published the first example of the reversal of cognitive decline. For five months his book, The End of Alzheimer’s, was on the New York Times Bestsellers List.